Timely treatment decisions: the promise of surrogate markers
The use of surrogate markers to make decisions about a treatment sooner can save lives. But it requires a compromise between waiting 20 years to approve a new treatment and rushing treatment decisions. It should be up to patients, clinicians, researchers, policymakers, and payers to work together to decide on the cost of that compromise effectively.
United States Thomasj Moore Centers For Medicaid Services Women Health Initiative National Institutes Of Health Drug Administration
Source: kevinmd.com